IL154509A0 - Infusion of ciprofoxacin having reduced acid content and being stable in storage - Google Patents

Infusion of ciprofoxacin having reduced acid content and being stable in storage

Info

Publication number
IL154509A0
IL154509A0 IL15450901A IL15450901A IL154509A0 IL 154509 A0 IL154509 A0 IL 154509A0 IL 15450901 A IL15450901 A IL 15450901A IL 15450901 A IL15450901 A IL 15450901A IL 154509 A0 IL154509 A0 IL 154509A0
Authority
IL
Israel
Prior art keywords
ciprofoxacin
infusion
stable
storage
acid content
Prior art date
Application number
IL15450901A
Other languages
English (en)
Original Assignee
Fresnius Kabi Deutschland Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fresnius Kabi Deutschland Gmbh filed Critical Fresnius Kabi Deutschland Gmbh
Publication of IL154509A0 publication Critical patent/IL154509A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/08—Plasma substitutes; Perfusion solutions; Dialytics or haemodialytics; Drugs for electrolytic or acid-base disorders, e.g. hypovolemic shock

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Inorganic Chemistry (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
IL15450901A 2000-09-29 2001-09-27 Infusion of ciprofoxacin having reduced acid content and being stable in storage IL154509A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10048510A DE10048510A1 (de) 2000-09-29 2000-09-29 Lagerstabile Infusionslösung des Ciprofloxacins mit verringertem Säuregehalt
PCT/EP2001/011189 WO2002026233A1 (de) 2000-09-29 2001-09-27 Lagerstabile infusionslösung des ciprofloxacins mit verringertem säuregehalt

Publications (1)

Publication Number Publication Date
IL154509A0 true IL154509A0 (en) 2003-09-17

Family

ID=7658237

Family Applications (1)

Application Number Title Priority Date Filing Date
IL15450901A IL154509A0 (en) 2000-09-29 2001-09-27 Infusion of ciprofoxacin having reduced acid content and being stable in storage

Country Status (17)

Country Link
US (1) US20040082593A1 (ja)
EP (1) EP1320368A1 (ja)
JP (1) JP2004509921A (ja)
KR (1) KR20030068541A (ja)
CN (1) CN1466457A (ja)
AU (1) AU2002214993A1 (ja)
BR (1) BR0114293A (ja)
CA (1) CA2420556A1 (ja)
DE (1) DE10048510A1 (ja)
HU (1) HUP0302256A2 (ja)
IL (1) IL154509A0 (ja)
MX (1) MXPA03002770A (ja)
NO (1) NO20031411D0 (ja)
PL (1) PL360597A1 (ja)
SK (1) SK3322003A3 (ja)
WO (1) WO2002026233A1 (ja)
ZA (1) ZA200301459B (ja)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA3062786C (en) 2010-07-09 2022-04-19 Janssen Vaccines & Prevention B.V. Anti-human respiratory syncytial virus (rsv) antibodies and methods of use
CN105338982B (zh) 2013-04-25 2017-10-10 杏林制药株式会社 固体药用组合物
CA2910121A1 (en) 2013-04-25 2014-10-30 Kyorin Pharmaceutical Co., Ltd. A pharmaceutical composition comprising a 1,4-dihydroquinoline carboxylic acid a cellulosic excipient and a salting-out agent
EP3210607A4 (en) 2014-10-23 2018-06-06 Kyorin Pharmaceutical Co., Ltd. Solid pharmaceutical composition
EP3305294A4 (en) 2015-06-02 2019-02-20 Kyorin Pharmaceutical Co., Ltd. AQUEOUS MEDICINE
WO2016195020A1 (ja) 2015-06-02 2016-12-08 杏林製薬株式会社 水性液剤
CA2988092A1 (en) 2015-06-02 2016-12-08 Kyorin Pharmaceutical Co., Ltd. Aqueous liquid formulation
CN114767627B (zh) * 2022-05-17 2024-05-31 广州南鑫药业有限公司 一种乳酸环丙沙星氯化钠注射液的制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3537761A1 (de) * 1985-10-24 1987-04-30 Bayer Ag Infusionsloesungen der 1-cyclopropyl-6-fluor-1,4-dihydro-4-oxo-7- (1-piperazinyl)-chinolin-3-carbonsaeure
WO1990001933A1 (en) * 1988-08-26 1990-03-08 Alcon Laboratories, Inc. Combination of quinolone antibiotics and steroids for topical ophthalmic use
DE10018783A1 (de) * 2000-04-15 2001-10-25 Fresenius Kabi De Gmbh Lagerstabile Infusionslösung des Ciprofloxacins mit verringertem Säuregehalt
DE10018781A1 (de) * 2000-04-15 2001-10-25 Fresenius Kabi De Gmbh Infusionslösungen des Ciprofloxacins mit verbesserter Lagerfähigkeit

Also Published As

Publication number Publication date
EP1320368A1 (de) 2003-06-25
WO2002026233B1 (de) 2002-07-04
HUP0302256A2 (hu) 2003-11-28
DE10048510A1 (de) 2002-05-16
JP2004509921A (ja) 2004-04-02
WO2002026233A1 (de) 2002-04-04
MXPA03002770A (es) 2004-12-13
US20040082593A1 (en) 2004-04-29
BR0114293A (pt) 2003-07-29
PL360597A1 (en) 2004-09-20
NO20031411D0 (no) 2003-03-27
CA2420556A1 (en) 2003-02-25
KR20030068541A (ko) 2003-08-21
AU2002214993A1 (en) 2002-04-08
CN1466457A (zh) 2004-01-07
ZA200301459B (en) 2003-08-27
SK3322003A3 (en) 2003-07-01

Similar Documents

Publication Publication Date Title
GB0005839D0 (en) Storage and delivery of micro-organisms
AU8270701A (en) Improvements in and relating to the use of honey in dressings
HK1041823A1 (zh) 含有乙酰水楊酸和氯吡格雷硫酸氫鹽的單位劑型形藥物組合物
AU2961602A (en) Improvements in and relating to the distribution of content
AU2002229616A1 (en) Improvements in and relating to the distribution of content
AU2002254942A1 (en) Paracetamol solutions which are stable in storage and ready for infusion
IL154509A0 (en) Infusion of ciprofoxacin having reduced acid content and being stable in storage
AU1773700A (en) Liquid starter cultures having improved storage stability and use thereof
AU8100301A (en) Storage stable tretinoin and 4-hydroxy anisole containing topical composition
GB9900276D0 (en) Improvements in or relating to connector and valves
EP1212604A4 (en) MOVEMENT OF A VOLUME IN A FACE
GB2336582B (en) Improvements in storage and display devices
AU2002226986A1 (en) In vivo delivery methods and compositions
GB0022260D0 (en) Improvements in and relating to bunding for storage of fluid materials
AU2001236313A1 (en) Storage and dispensing receptacle
GB0028850D0 (en) Container storage and secure unattended delivery of goods
AU4851601A (en) Storage and transport vessel
GB2356341B (en) Improvements in and relating to furniture
GB2371596B (en) Improvements in and relating to lockable storage containers
GB0031367D0 (en) Improvements in and relating to the distribution of content
GB0010674D0 (en) Improvements in and relating to transit trays
GB2381934B (en) Improvements in and relating to devices for storage
GB0024016D0 (en) Storage and delivery means
AU2001237381A1 (en) Use of palatinase and trehalulase sequences as nutritive markers in transformed cells
PL349370A1 (en) Liquid starter cultures having improved storage stability and use thereof